Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Transcription

1 Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program

2 I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic)

3 (3) other qualities (e.g., Gram s stain positive or Gram s stain negative)

4 Choice of ntimicrobial Therapy based on the morphology and growth patterns of microorganisms

5

6

7

8 II. Empirical Therapy empirical therapy is often based on a working knowledge of the most likely pathogens expected to be found at the site of infection certain organisms are predictably associated with infection at certain tissue sites and not in others certain host factors such as age, immunosuppression, prior antibiotic usage, and environment help to predict the most likely organism

9

10 II. Empirical Therapy (cont.)

11 III. Selection of an Antimicrobial Agent selection of an antimicrobial agent for some infections can await the results of appropriate culture and susceptibility (C & S) testing

12 III. Selection of an Antimicrobial Agent (cont.) C & S Testing

13 III. Selection of an Antimicrobial Agent (cont.)

14 ANTIMICROBIAL MECHANISMS OF ACTION

15

16 Treatment of Uncomplicated UTI (Outpatient) Pathogens E. Coli Proteus mirabilis Klebsiella pneumoniae Enterococcus faecalis Staph saprophyticus Oral Antibiotic(s) of Choice Bactrim DS / Septra DS Sulfamethoxazole / Trimethoprim OR: 1 st general CEPH e.g., cephalexin (Keflex) OR: Fluoroquinolone e.g., Ciprofloxacin (Cipro) or Levofloxacin (Levaquin) Complicated UTI (ESBL pathogens) meropenem (Merrem) 500 mg IV Q6H ertepenem (Invanz) 1 gm IV/IM Q24H

17 Treatment of Pyelonephritis (Inpatient) Pathogens E. Coli Klebsiella pneumoniae Enterobacter sp. Pseudomonas aeruginosa Oral Antibiotic(s) of Choice Ceftriaxone (Rocephin) 1 GM IV Q24H OR: Ciprofloxacin 400 mg IV Q12H* Levofloxacin 500 mg IV/PO Q24H OR: AGLY**: Gentamicin / Tobramycin 5 7 mg/kg/day IV once daily * Ciprofloxacin 500 mg PO BID ** AGLY = aminoglycoside

18 Tx of Community-Acquired Pneumonia (Inpatient) Pathogens S. pneumoniae (12-68%) H. influenza (2.5-45%) Mycoplasma pneumoniae Chlamydia pneumoniae Legionella species Antimicrobial Drug(s) of Choice Ceftriaxone 1 GM IVPB Q24H PLUS Azithromycin 500 mg IVPB 24H OR Levofloxacin mg IVPB Q24H

19 Tx of Hospital (Nosocomial) Acquired Pneumonia (HAP) Pathogens Staphylococcus aureus Klebsiella pneumoniae E. Coli Psuedomonas aeruginosa Antibiotic(s) of Choice Vancomycin 15 mg/kg/dose IV Q12H AND Cefepime 2 GM IVPB Q8H OR Ceftazidime 2 GM IVPB Q8H OR Zosyn (Piperacillin-Tazobactam) 4.5 GM IVPB Q6H OR Levofloxacin 500 MG IVPB Q24H Aspiration Pneumonia!!! ADD: Clindamycin 600 mg IVPB Q8H Ceftazidime (Fortaz), Cefepime (Maxipime), Levofloxacin (Levaquin), clindamycin (Cleocin)

20 Treatment of Meningitis (Community-Acquired) Pathogens Streptococcus pneumoniae (pneumococcus) Neisseria meningitidis (meningococcus) Antibiotics of Choice Ceftriaxone 2 GM IV Q12H PLUS Vancomycin 15 mg/kg IV Q8H PLUS Acyclovir 10 mg/kg/dose IV Q8H Ceftriaxone (Rocephin), Acyclovir (Zovirax)

21 Treatment of Intra-Abdominal Sepsis (e.g., Peritonitis, Cholecystitis) Pathogens Gram-negative bacteria Streptococci, anaerobic bacteria: Clostridium sp. Bacteroides sp. Antibiotics of Choice Zosyn (Piperacillin-Tazobactram) 4.5 GM IV Q6H OR Ertapenem (Primaxin) 1 GM IV Q24H

22 Treatment Helicobacter pylori (H. pylori) PrevPac! Lansoprazole (Prevacid) 30 mg PO BID x 10 days! Amoxicillin (Amoxil) 1000 mg PO BID x 10 days! Clarithromycin (Biaxin) 500 mg PO BID x 10 days Treatment of Cellulitis / Osteomyelitis Cellulitis! Cephalexin (Keflex) 500 mg PO QID, AND! SMX-TMP (Bactrim DS) PO BID Osteomyelitis! Vancomycin 15 mg/kg/dose IV Q12H, AND! Clindamycin 600 mg IV Q8H

23